Tag: Lifileucel approval

Home / Lifileucel approval

Categories

Lifileucel is approved by the USFDA for unresectable or metastatic melanoma

The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or met...
lifileucel-approval

Scan the code